The University of Chicago Header Logo

Connection

Larry Goldstein to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Larry Goldstein has written about Treatment Outcome.
Larry Goldstein
Connection Strength
1.057
Treatment Outcome
  1. Hospital Quality Metrics: "America's Best Hospitals" and Outcomes After Ischemic Stroke. J Stroke Cerebrovasc Dis. 2019 Feb; 28(2):430-434.
    View in: PubMed
    Score: 0.069
  2. Modern medical management of acute ischemic stroke. Methodist Debakey Cardiovasc J. 2014 Apr-Jun; 10(2):99-104.
    View in: PubMed
    Score: 0.050
  3. JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes. Neurology. 2013 Jul 30; 81(5):448-55.
    View in: PubMed
    Score: 0.047
  4. Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers. Neurology. 2011 06 07; 76(23):1976-82.
    View in: PubMed
    Score: 0.041
  5. Statins after intracerebral hemorrhage: to treat or not to treat. Arch Neurol. 2011 May; 68(5):565-6.
    View in: PubMed
    Score: 0.040
  6. Postendarterectomy mortality in octogenarians and nonagenarians in the USA from 1993 to 1999. Cerebrovasc Dis. 2010 Jan; 29(2):154-61.
    View in: PubMed
    Score: 0.037
  7. Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. Stroke. 2009 Nov; 40(11):3574-9.
    View in: PubMed
    Score: 0.036
  8. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009 Nov; 40(11):3526-31.
    View in: PubMed
    Score: 0.036
  9. The cart and the horse: the advancing technology of carotid artery stenting. Circ Cardiovasc Interv. 2009 Jun; 2(3):153-5.
    View in: PubMed
    Score: 0.036
  10. The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation. 2009 Jun 09; 119(22):2955-62.
    View in: PubMed
    Score: 0.035
  11. Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. Stroke. 2009 Jun; 40(6):2116-22.
    View in: PubMed
    Score: 0.035
  12. JUPITER and the world of stroke medicine. Lancet Neurol. 2009 Feb; 8(2):129-31.
    View in: PubMed
    Score: 0.035
  13. Poststroke treatment: lost in translation. Stroke. 2009 Jan; 40(1):8-9.
    View in: PubMed
    Score: 0.034
  14. Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008 Sep; 39(9):2444-8.
    View in: PubMed
    Score: 0.033
  15. Impact of comorbidities on ischemic stroke outcomes in women. Stroke. 2008 Jul; 39(7):2138-40.
    View in: PubMed
    Score: 0.033
  16. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke. 2004 Oct; 35(10):2425-7.
    View in: PubMed
    Score: 0.026
  17. Aspirin: it's hard to beat. Neurology. 2004 Apr 13; 62(7):1036-7.
    View in: PubMed
    Score: 0.025
  18. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004 Feb 07; 363(9407):414-5.
    View in: PubMed
    Score: 0.025
  19. Prevention and health services delivery. Stroke. 2004 Feb; 35(2):401-3.
    View in: PubMed
    Score: 0.025
  20. Extracranial carotid artery stenosis. Stroke. 2003 Nov; 34(11):2767-73.
    View in: PubMed
    Score: 0.024
  21. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology. 2003 Sep 23; 61(6):792-6.
    View in: PubMed
    Score: 0.024
  22. Prevention and health services delivery. Stroke. 2003 Feb; 34(2):367-9.
    View in: PubMed
    Score: 0.023
  23. Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. J Am Coll Cardiol. 2020 05 05; 75(17):2110-2118.
    View in: PubMed
    Score: 0.019
  24. Outcomes after carotid endarterectomy among elderly dual Medicare-Medicaid-eligible patients. Neurology. 2018 10 23; 91(17):e1553-e1558.
    View in: PubMed
    Score: 0.017
  25. Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke. Stroke. 2018 09; 49(9):2138-2146.
    View in: PubMed
    Score: 0.017
  26. Potential effects of common drugs on stroke recovery. Arch Neurol. 1998 Apr; 55(4):454-6.
    View in: PubMed
    Score: 0.016
  27. Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. Stroke. 1997 Jun; 28(6):1181-4.
    View in: PubMed
    Score: 0.016
  28. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997 Feb; 28(2):307-10.
    View in: PubMed
    Score: 0.015
  29. Ischemic Stroke with Troponin Elevation: Patient Characteristics, Resource Utilization, and In-Hospital Outcomes. Cerebrovasc Dis. 2016; 42(3-4):213-23.
    View in: PubMed
    Score: 0.014
  30. Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. J Neurol Neurosurg Psychiatry. 1995 Jun; 58(6):753-5.
    View in: PubMed
    Score: 0.013
  31. A geographic information system analysis of the impact of a statewide acute stroke emergency medical services routing protocol on community hospital bypass. J Stroke Cerebrovasc Dis. 2014 Nov-Dec; 23(10):2800-2808.
    View in: PubMed
    Score: 0.013
  32. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke. 1994 Jun; 25(6):1116-21.
    View in: PubMed
    Score: 0.013
  33. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
    View in: PubMed
    Score: 0.012
  34. Compliance with acute stroke care quality measures in hospitals with and without primary stroke center certification: the North Carolina Stroke Care Collaborative. J Am Heart Assoc. 2014 Apr 10; 3(2):e000423.
    View in: PubMed
    Score: 0.012
  35. Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):778-84.
    View in: PubMed
    Score: 0.012
  36. Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. Stroke. 2012 Jul; 43(7):1858-64.
    View in: PubMed
    Score: 0.011
  37. Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol. 2011 Oct 04; 58(15):1557-65.
    View in: PubMed
    Score: 0.010
  38. Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke. 2011 Feb; 6(1):42-6.
    View in: PubMed
    Score: 0.010
  39. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul; 40(7):2486-92.
    View in: PubMed
    Score: 0.009
  40. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke. 2009 Apr; 40(4):1405-9.
    View in: PubMed
    Score: 0.009
  41. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec; 39(12):3297-302.
    View in: PubMed
    Score: 0.009
  42. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.
    View in: PubMed
    Score: 0.008
  43. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec; 38(12):3198-204.
    View in: PubMed
    Score: 0.008
  44. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002 Jul; 33(7):1934-42.
    View in: PubMed
    Score: 0.006
  45. Recommendations for improving the quality of care through stroke centers and systems: an examination of stroke center identification options: multidisciplinary consensus recommendations from the Advisory Working Group on Stroke Center Identification Options of the American Stroke Association. Stroke. 2002 Jan; 33(1):e1-7.
    View in: PubMed
    Score: 0.005
  46. Gram-Negative anaerobic endocarditis: two case reports and review of the literature. Eur J Clin Microbiol Infect Dis. 2001 Sep; 20(9):651-4.
    View in: PubMed
    Score: 0.005
  47. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl. 2000 Nov; 6(6):741-8.
    View in: PubMed
    Score: 0.005
  48. Transjugular intrahepatic portosystemic shunts: impact on liver transplantation. Liver Transpl Surg. 1995 Jul; 1(4):229-33.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.